has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.
Pro
Pro
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: